Some studies demonstrate that myriocin ameliorates clinical manifestations of insulin resistance such as peripheral glucose tolerance and upregulates insulin-stimulated Akt phosphorylation, thus preventing clinical transformation to frank T2DM in both genetic and diet-induced models of diabetes [217,319,320]. This evidence concerns the gene INS and diabetes mellitus.